Latest News
Press background on Claris Lifesciences Limited
Company profile
Claris Lifesciences Limited (BSE Code: 533288) is one of the largest sterile injectables pharmaceutical companies in India. The company manufactures and markets products across various therapeutic segments including Anaesthesia, Plasma Volume Expanders, Blood Products, Parenteral & Enteral Nutrition, Infusion therapy, Anti-infective and Renal Care. A significant majority of these products are generic drugs that are capable of being directly injected into the human body and are predominantly used in the treatment of critical illnesses. The company has 3 manufacturing plants; at its campus on the out skirts of Ahmedabad. With emphasis on Quality, Technology & Innovation, Claris offers a range of niche technology-driven injectable products across delivery systems such as glass bottles, glass vials & ampoules, and non-PVC/PVC bags. Claris’ sterile injectables facilities have been approved by regulatory authorities including USFDA, MHRA (UK), TGA (Australia), and GCC FDCA. The company’s manufacturing capabilities have several times received awards from prestigious institutions like Frost & Sullivan and IDMA. For more information about the company, log on to: www.clarislifesciences.com
 Recent press releases
Claris Announces Receipt of EIR from the US FDA

One of India’s largest sterile Injectables company, Claris Lifesciences Limited (Claris/Company), announced today that it has received the Establishment Inspection Report (EIR) for its manufacturing facility located near Ahmedabad, wherein the US FDA has concluded that the inspection ... (more)
Share
Claris Lifesciences Consolidated Q1FY16 PAT Rises 31%

Claris Lifesciences Ltd. (CU) today announced its Un-Audited Financial Results for the quarter ended 30th June 2015 at its board meeting held at its registered office in Ahmedabad.
 
Management Representation of the Financial of the Speciality Injectable Business:
... (more)
Share
Claris Lifesciences Limited Audited Financial Results for the Quarter and Financial Year (Fifteen Months) Ended 31st March 2015

Claris Lifesciences Ltd. (CLL) today announced its Audited Financial Results for the quarter and financial year (fifteen months] ended 31st March 2015 at its board meeting held at its registered office in Ahmedabad.
 
Management Representation of the Financial of t... (more)
Share
Claris Lifesciences Limited Un-Audited Financial Results for the Quarter Ended 30th September 2014

Claris Lifesciences Ltd. (CLL) announced its quarterly un-audited financial results for the quarter ended 30th September 2014 at its board meeting held at its registered office in Ahmedabad.
 
On the 31st of October, after the receipt of the Board and Sharehol... (more)
Share
Claris Lifesciences Receives MHRA Approval for New Plant

Claris Lifesciences Limited (Company) has today announced it has received the MHRA approval for its newly commissioned plant (Plant 2). This will help in enhancing capacities to grow in the regulated markets, especially the European Union. The Company's specialty injectables business sa... (more)
Share
Claris Lifesciences Limited Un-audited Financial Results for the Quarter Ended 30th June 2014

Claris Lifesciences Ltd. today announced its quarterly and half yearly un-audited financial results for the quarter and half year ended 30th June 2014 at its board meeting held at its registered office in Ahmedabad.
Key Financial Highlights of Consolidated Numbers:
&mid... (more)
Share